Urticarial Vasculitis After First Denosumab Injection in an Osteoporotic Woman Diagnosed with Cushing’s Syndrome
Denosumab is a human-derived monoclonal immunoglobulin G2 antibody against the receptor activator of nuclear factor kappa B ligand, inhibiting the differentiation and function of osteoclast precursor cells by its antiosteoclastic action. Denosumab is approved for postmenopausal, glucocorti coid-indu...
שמור ב:
| Principais autores: | , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Society of Endocrinology and Metabolism of Turkey
2022-09-01
|
| סדרה: | Endocrinology Research and Practice |
| נושאים: | |
| גישה מקוונת: | https://endocrinolrespract.org/index.php/pub/article/view/1123 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|